How much funding can be received?

Funds up to 50% of admissible expenses, capped at $1500000 per project.

What is the deadline to apply?

The deadline to apply is not specified.

Who are the financial supporters of the CQDM — PARTENAR-IA — Academic?

CQDM — PARTENAR-IA — Academic is funded by Quebec Consortium for Drug Discovery (CQDM)

What are CQDM — PARTENAR-IA — Academic's eligibility criterias?

A minimum of two businesses must conduct R&D or production activities in Quebec, with at least one SME having 250 employees. The project must include collaboration with Quebec-based research institutions, such as universities, hospitals, CCTTs, or public research centers. Each participating business must hire at least one intern per year for the duration of the project.

CQDM — PARTENAR-IA — Academic

grant_single|update March 16, 2025

QC, Canada

Funding for Quebec biopharmaceutical R&D collaborations in AI

grant_single_labels|summary

grant_single_labels|preview

grant_single_labels|terms_and_conditions

grant_single_labels|projects

grant_single_labels|admissibility

grant_single_labels|criteria

grant_single_labels|apply

grant_single_labels|otherInfo

grant_single_labels|contact

grant_single_labels|summary

grant_single|eligibleFinancing

grant_single|maxCount
grant_single|projectCostPercent

grant_single|deadlines

grant_single|openingDate April 15, 2025

grant_single|financingType

Grant and Funding

grant_single|eligibleIndustries

Health care and social assistance

grant_single|grantors

Quebec Consortium for Drug Discovery (CQDM)

grant_single|status

grant_card_status|open

grant_single_labels|preview

Get a non-refundable grant up to $500,000 to cover up to 40% of eligible expenses when your SME partners with a research centre on an artificial intelligence project that accelerates drug discoveries.

grant_single_labels|terms_and_conditions

This grant offers structured financing modalities designed to support collaborative biopharmaceutical R&D projects using artificial intelligence in Quebec. The financing is carefully determined to align with project scale and partnership dynamics.

Maximum support rate is up to 50% of eligible expenses for both the business and the research institution involved.
Financial support is capped at $350,000 per eligible partner business, with a total possible allocation of $1,500,000 for a project with five businesses.
For projects involving two businesses, the maximum grant available is $700,000, contingent on the project's total value not exceeding $1.4 million.
The project must secure a minimal industrial contribution of 25%, either in cash or in kind, from the participating businesses.

grant_single_labels|projects

This grant is designed to support biopharmaceutical R&D projects in Quebec that leverage artificial intelligence through collaborative efforts. It fosters partnerships between businesses, particularly SMEs, and research institutions to advance innovation.

Collaborative R&D projects using artificial intelligence between multiple Quebec-based businesses and research institutions.

grant_single|admissibleProjectsExample

$ 220,000

AI algorithm development for neurodegenerative disease drug research

$ 196,000

Using AI to optimize drug formulation processes for oncology

$ 220,000

AI-enhanced cardiovascular drug development project

$ 200,000

Leveraging AI to accelerate antibiotic resistance research

$ 180,000

Developing AI for drug interaction predictions in a lab setting

$ 180,000

Creating an AI-driven platform for rare disease drug discovery

grant_single_labels|admissibility

Eligibility for the Partenar-IA grant is determined by specific requirements that firms must meet to qualify.

The project must involve a minimum of two businesses conducting R&D or production activities in Quebec.
At least one of the participating businesses must be a small or medium-sized enterprise (SME) with at least 250 employees.
The project must be carried out in collaboration with one or several research institutions in Quebec, ensuring at least 20% of the project's involvement is with these institutions, such as universities, hospitals, CCTTs, or public research centers.
Each participating business is required to hire at least one intern per year for the duration of the project.
The project must demonstrate a minimal industrial contribution of 25%, which can be in cash and/or in kind.
External funding from non-MEIE sources can cover, at most, 25% of the project's funding arrangement.
The project should have a maximum duration of 2 years.

grant_eligibility_criteria|who_can_apply

This grant supports collaborative R&D projects in biopharmaceuticals using AI by businesses in Quebec.

Collaborative projects between at least two businesses involved in biopharmaceutical R&D in Quebec, with participation from research institutions.
Involvement of at least one SME with a minimum of 250 employees based in Quebec.
Commitment to hire at least one intern per year throughout the project duration.
Requirement for a minimum industrial contribution of 25% towards the project, either in cash or in kind.
Projects receiving funding from other non-MEIE sources, capped at 25% of the total funding arrangement.
Projects should have a maximum duration of 2 years.

grant_eligibility_criteria|who_cannot_apply

Some companies may not be eligible for this grant due to specific exclusion criteria. For example, companies involved in tobacco, alcohol, or adult entertainment industries might not qualify.

Companies engaged in illegal activities.
Non-profit organizations.
Companies not registered or operating in Canada.
Government entities or agencies.

grant_eligibility_criteria|eligible_expenses

Partenar-IA grant is designed to support collaborative R&D projects in the biopharmaceutical sector in Quebec utilizing artificial intelligence. The program aims to foster collaboration between businesses and research institutions to advance technological innovations.

Collaborative R&D projects involving AI applications in biopharmaceutical processes.
Innovative projects enhancing drug discovery and development through machine learning and data analytics.
Integration of AI technologies for improving healthcare outcomes and biomanufacturing efficiency.
Initiatives involving interdisciplinary teams from industries and academic institutions.
Projects contributing to the advancement of personalized medicine through AI-driven insights.

grant_eligibility_criteria|zone

This grant is targeted towards businesses conducting activities in Quebec, reflecting regional development priorities and collaboration goals.

Businesses with R&D or production activities within Quebec.

grant_single_labels|criteria

There are evaluation and selection criteria for this grant. The criteria include but are not limited to the applicant's innovation level, impact on the community, and financial viability.

Applicant's innovation level
Impact on the community
Financial viability

grant_single_labels|apply

grant_single_labels|otherInfo

Here are additional relevant details for this grant:

Strong emphasis is placed on cross-sector collaboration between businesses and research institutions.
Successful applicants may receive guidance and support from the grant provider throughout the project duration.
The program aims to strengthen Quebec's position in the biopharmaceutical and AI sectors.
Projects should demonstrate potential for significant advancements or innovations in biopharmaceutical applications.